Table of Contents Executive Summary 1 Industry Overview of Hepatitis C Drugs 1.1 Definition of Hepatitis C Drugs 1.2 Hepatitis C Drugs Segment By Drug Class 1.2.1 Global Hepatitis C Drugs Production Growth Rate Comparison By Drug Class (2014-2025) 1.2.2 Anti-Viral 1.2.3 Immuno-modulators 1.2.4 Others 1.3 Hepatitis C Drugs Segment by Applications 1.3.1 Global Hepatitis C Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.4 Global Hepatitis C Drugs Overall Market 1.4.1 Global Hepatitis C Drugs Revenue (2014-2025) 1.4.2 Global Hepatitis C Drugs Production (2014-2025) 1.4.3 North America Hepatitis C Drugs Status and Prospect (2014-2025) 1.4.4 Europe Hepatitis C Drugs Status and Prospect (2014-2025) 1.4.5 China Hepatitis C Drugs Status and Prospect (2014-2025) 1.4.6 Japan Hepatitis C Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Hepatitis C Drugs Status and Prospect (2014-2025) 1.4.8 India Hepatitis C Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Hepatitis C Drugs 2.3 Manufacturing Process Analysis of Hepatitis C Drugs 2.4 Industry Chain Structure of Hepatitis C Drugs 3 Development and Manufacturing Plants Analysis of Hepatitis C Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Hepatitis C Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Hepatitis C Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Hepatitis C Drugs Production and Capacity Analysis 4.2 Hepatitis C Drugs Revenue Analysis 4.3 Hepatitis C Drugs Price Analysis 4.4 Market Concentration Degree 5 Hepatitis C Drugs Regional Market Analysis 5.1 Hepatitis C Drugs Production by Regions 5.1.1 Global Hepatitis C Drugs Production by Regions 5.1.2 Global Hepatitis C Drugs Revenue by Regions 5.2 Hepatitis C Drugs Consumption by Regions 5.3 North America Hepatitis C Drugs Market Analysis 5.3.1 North America Hepatitis C Drugs Production 5.3.2 North America Hepatitis C Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Hepatitis C Drugs Import and Export 5.4 Europe Hepatitis C Drugs Market Analysis 5.4.1 Europe Hepatitis C Drugs Production 5.4.2 Europe Hepatitis C Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Hepatitis C Drugs Import and Export 5.5 China Hepatitis C Drugs Market Analysis 5.5.1 China Hepatitis C Drugs Production 5.5.2 China Hepatitis C Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Hepatitis C Drugs Import and Export 5.6 Japan Hepatitis C Drugs Market Analysis 5.6.1 Japan Hepatitis C Drugs Production 5.6.2 Japan Hepatitis C Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Hepatitis C Drugs Import and Export 5.7 Southeast Asia Hepatitis C Drugs Market Analysis 5.7.1 Southeast Asia Hepatitis C Drugs Production 5.7.2 Southeast Asia Hepatitis C Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Hepatitis C Drugs Import and Export 5.8 India Hepatitis C Drugs Market Analysis 5.8.1 India Hepatitis C Drugs Production 5.8.2 India Hepatitis C Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Hepatitis C Drugs Import and Export 6 Hepatitis C Drugs Segment Market Analysis (by Type) 6.1 Global Hepatitis C Drugs Production by Type 6.2 Global Hepatitis C Drugs Revenue by Type 6.3 Hepatitis C Drugs Price by Type 7 Hepatitis C Drugs Segment Market Analysis (by Application) 7.1 Global Hepatitis C Drugs Consumption by Application 7.2 Global Hepatitis C Drugs Consumption Market Share by Application (2014-2019) 8 Hepatitis C Drugs Major Manufacturers Analysis 8.1 Gilead sciences 8.1.1 Gilead sciences Hepatitis C Drugs Production Sites and Area Served 8.1.2 Gilead sciences Product Introduction, Application and Specification 8.1.3 Gilead sciences Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Abbvi 8.2.1 Abbvi Hepatitis C Drugs Production Sites and Area Served 8.2.2 Abbvi Product Introduction, Application and Specification 8.2.3 Abbvi Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Johnson & Johnson 8.3.1 Johnson & Johnson Hepatitis C Drugs Production Sites and Area Served 8.3.2 Johnson & Johnson Product Introduction, Application and Specification 8.3.3 Johnson & Johnson Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Merck 8.4.1 Merck Hepatitis C Drugs Production Sites and Area Served 8.4.2 Merck Product Introduction, Application and Specification 8.4.3 Merck Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Glaxosmithkline 8.5.1 Glaxosmithkline Hepatitis C Drugs Production Sites and Area Served 8.5.2 Glaxosmithkline Product Introduction, Application and Specification 8.5.3 Glaxosmithkline Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Novartis 8.6.1 Novartis Hepatitis C Drugs Production Sites and Area Served 8.6.2 Novartis Product Introduction, Application and Specification 8.6.3 Novartis Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Bristol-Myers Squibb 8.7.1 Bristol-Myers Squibb Hepatitis C Drugs Production Sites and Area Served 8.7.2 Bristol-Myers Squibb Product Introduction, Application and Specification 8.7.3 Bristol-Myers Squibb Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Roche 8.8.1 Roche Hepatitis C Drugs Production Sites and Area Served 8.8.2 Roche Product Introduction, Application and Specification 8.8.3 Roche Hepatitis C Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 9 Development Trend of Analysis of Hepatitis C Drugs Market 9.1 Global Hepatitis C Drugs Market Trend Analysis 9.1.1 Global Hepatitis C Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Hepatitis C Drugs Regional Market Trend 9.2.1 North America Hepatitis C Drugs Forecast 2019-2025 9.2.2 Europe Hepatitis C Drugs Forecast 2019-2025 9.2.3 China Hepatitis C Drugs Forecast 2019-2025 9.2.4 Japan Hepatitis C Drugs Forecast 2019-2025 9.2.5 Southeast Asia Hepatitis C Drugs Forecast 2019-2025 9.2.6 India Hepatitis C Drugs Forecast 2019-2025 9.3 Hepatitis C Drugs Market Trend (Product Type) 9.4 Hepatitis C Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Hepatitis C Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Hepatitis C Drugs Table Global Hepatitis C Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Hepatitis C Drugs Production Market Share by Types in 2018 Figure Anti-Viral Product Picture Figure Immuno-modulators Product Picture Figure Others Product Picture Table Global Hepatitis C Drugs Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Hepatitis C Drugs Consumption Market Share by Applications in 2018 Figure Hospitals Figure Clinics Figure Global Hepatitis C Drugs Revenue (Million USD) (2014-2025) Figure Global Hepatitis C Drugs Production (K Units) (2014-2025) Figure North America Hepatitis C Drugs Market Size (Million USD) (2014-2025) Figure Europe Hepatitis C Drugs Market Size (Million USD) (2014-2025) Figure China Hepatitis C Drugs Market Size (Million USD) (2014-2025) Figure Japan Hepatitis C Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Hepatitis C Drugs Market Size (Million USD) (2014-2025) Figure India Hepatitis C Drugs Market Size (Million USD) (2014-2025) Table Hepatitis C Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Hepatitis C Drugs in 2018 Figure Manufacturing Process Analysis of Hepatitis C Drugs Figure Industry Chain Structure of Hepatitis C Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Hepatitis C Drugs Manufacturing Plants Distribution Table Hepatitis C Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Hepatitis C Drugs Capacity (K Units) of Major Manufacturers (2014-2019) Table Hepatitis C Drugs Production (K Units) of Major Manufacturers (2014-2019) Table Hepatitis C Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Hepatitis C Drugs Production Share by Manufacturers in 2018 Table Hepatitis C Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Hepatitis C Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Hepatitis C Drugs Revenue Share by Manufacturers in 2018 Table Hepatitis C Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Hepatitis C Drugs Production by Regions 2014-2019 (K Units) Table Global Hepatitis C Drugs Production Market Share by Regions 2014-2019 Figure Global Hepatitis C Drugs Production Market Share by Regions in 2018 Table Global Hepatitis C Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Hepatitis C Drugs Revenue Market Share by Regions 2014-2019 Figure Global Hepatitis C Drugs Revenue Market Share by Regions in 2018 Table Global Hepatitis C Drugs Consumption by Regions 2014-2019 (K Units) Table Global Hepatitis C Drugs Consumption Market Share by Regions 2014-2019 Figure North America Hepatitis C Drugs Production Growth Rate 2014-2019 (K Units) Figure North America Hepatitis C Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Hepatitis C Drugs Production, Consumption Import and Export (K Units) Figure Europe Hepatitis C Drugs Production Growth Rate 2014-2019 (K Units) Figure Europe Hepatitis C Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Hepatitis C Drugs Production, Consumption Import and Export (K Units) Figure China Hepatitis C Drugs Production Growth Rate 2014-2019 (K Units) Figure China Hepatitis C Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Hepatitis C Drugs Production, Consumption Import and Export (K Units) Figure Japan Hepatitis C Drugs Production Growth Rate 2014-2019 (K Units) Figure Japan Hepatitis C Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Hepatitis C Drugs Production, Consumption Import and Export (K Units) Figure Southeast Asia Hepatitis C Drugs Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Hepatitis C Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Hepatitis C Drugs Production, Consumption Import and Export (K Units) Figure India Hepatitis C Drugs Production Growth Rate 2014-2019 (K Units) Figure India Hepatitis C Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Hepatitis C Drugs Production, Consumption Import and Export (K Units) Figure Global Consumption Hepatitis C Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Hepatitis C Drugs Market Share by Application (2014-2019) Table Gilead sciences Hepatitis C Drugs Production Sites and Area Served Table Gilead sciences Hepatitis C Drugs Product Introduction, Application and Specification Table Gilead sciences Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Gilead sciences Hepatitis C Drugs Production Growth Rate (2014-2019) Table Gilead sciences Hepatitis C Drugs Production Market Share (2014-2019) Figure Gilead sciences Hepatitis C Drugs Revenue Market Share (2014-2019) Table Gilead sciences Hepatitis C Drugs Main Business and Markets Served Table Abbvi Hepatitis C Drugs Production Sites and Area Served Table Abbvi Hepatitis C Drugs Product Introduction, Application and Specification Table Abbvi Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Abbvi Hepatitis C Drugs Production Growth Rate (2014-2019) Table Abbvi Hepatitis C Drugs Production Market Share (2014-2019) Figure Abbvi Hepatitis C Drugs Revenue Market Share (2014-2019) Table Abbvi Hepatitis C Drugs Main Business and Markets Served Table Johnson & Johnson Hepatitis C Drugs Production Sites and Area Served Table Johnson & Johnson Hepatitis C Drugs Product Introduction, Application and Specification Table Johnson & Johnson Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson Hepatitis C Drugs Production Growth Rate (2014-2019) Table Johnson & Johnson Hepatitis C Drugs Production Market Share (2014-2019) Figure Johnson & Johnson Hepatitis C Drugs Revenue Market Share (2014-2019) Table Johnson & Johnson Hepatitis C Drugs Main Business and Markets Served Table Merck Hepatitis C Drugs Production Sites and Area Served Table Merck Hepatitis C Drugs Product Introduction, Application and Specification Table Merck Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Hepatitis C Drugs Production Growth Rate (2014-2019) Table Merck Hepatitis C Drugs Production Market Share (2014-2019) Figure Merck Hepatitis C Drugs Revenue Market Share (2014-2019) Table Merck Hepatitis C Drugs Main Business and Markets Served Table Glaxosmithkline Hepatitis C Drugs Production Sites and Area Served Table Glaxosmithkline Hepatitis C Drugs Product Introduction, Application and Specification Table Glaxosmithkline Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Glaxosmithkline Hepatitis C Drugs Production Growth Rate (2014-2019) Table Glaxosmithkline Hepatitis C Drugs Production Market Share (2014-2019) Figure Glaxosmithkline Hepatitis C Drugs Revenue Market Share (2014-2019) Table Glaxosmithkline Hepatitis C Drugs Main Business and Markets Served Table Novartis Hepatitis C Drugs Production Sites and Area Served Table Novartis Hepatitis C Drugs Product Introduction, Application and Specification Table Novartis Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Hepatitis C Drugs Production Growth Rate (2014-2019) Table Novartis Hepatitis C Drugs Production Market Share (2014-2019) Figure Novartis Hepatitis C Drugs Revenue Market Share (2014-2019) Table Novartis Hepatitis C Drugs Main Business and Markets Served Table Bristol-Myers Squibb Hepatitis C Drugs Production Sites and Area Served Table Bristol-Myers Squibb Hepatitis C Drugs Product Introduction, Application and Specification Table Bristol-Myers Squibb Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Hepatitis C Drugs Production Growth Rate (2014-2019) Table Bristol-Myers Squibb Hepatitis C Drugs Production Market Share (2014-2019) Figure Bristol-Myers Squibb Hepatitis C Drugs Revenue Market Share (2014-2019) Table Bristol-Myers Squibb Hepatitis C Drugs Main Business and Markets Served Table Roche Hepatitis C Drugs Production Sites and Area Served Table Roche Hepatitis C Drugs Product Introduction, Application and Specification Table Roche Hepatitis C Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Hepatitis C Drugs Production Growth Rate (2014-2019) Table Roche Hepatitis C Drugs Production Market Share (2014-2019) Figure Roche Hepatitis C Drugs Revenue Market Share (2014-2019) Table Roche Hepatitis C Drugs Main Business and Markets Served Figure Global Hepatitis C Drugs Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Hepatitis C Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Hepatitis C Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Hepatitis C Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Hepatitis C Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Hepatitis C Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Hepatitis C Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Hepatitis C Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure China Hepatitis C Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Hepatitis C Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Hepatitis C Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Hepatitis C Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Hepatitis C Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Hepatitis C Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure India Hepatitis C Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Hepatitis C Drugs by Type (2019-2025) Table Global Consumption (K Units) of Hepatitis C Drugs by Application (2019-2025) Table Hepatitis C Drugs Distributors List Table Hepatitis C Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Gilead sciences Abbvi Johnson & Johnson Merck Glaxosmithkline Novartis Bristol-Myers Squibb Roche